Key Statistics
Market Cap$26.71M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$0.79
52W High$13.25
52W Low$3.10
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees8
Price Performance
1 Week-5.10%
3 Month-25.58%
1 Year-68.33%
FinancialsAnnual · QuiverQuant
Revenue$0
Assets$11.58M
Liabilities$8.55M
Net Income$16.91M loss
About
Exicure, Inc., a clinical-stage biotechnology company, develops therapies for neurology, immuno-oncology, inflammatory diseases, and genetic disorders based on its proprietary spherical nucleic acid (SNA) technology. The company is headquartered in Chicago, Illinois.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze XCUR with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.